.css-1xsl8rf{width:100%;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;position:relative;overflow:hidden;background:var(--alert-bg);-webkit-padding-start:var(--chakra-space-4);padding-inline-start:var(--chakra-space-4);-webkit-padding-end:var(--chakra-space-4);padding-inline-end:var(--chakra-space-4);padding-top:var(--chakra-space-1);padding-bottom:var(--chakra-space-1);--alert-fg:var(--chakra-colors-orange-600);--alert-bg:var(--chakra-colors-orange-100);font-weight:var(--chakra-fontWeights-semibold);padding-left:var(--chakra-space-4);}.chakra-ui-dark .css-1xsl8rf:not([data-theme]),[data-theme=dark] .css-1xsl8rf:not([data-theme]),.css-1xsl8rf[data-theme=dark]{--alert-fg:var(--chakra-colors-orange-200);--alert-bg:rgba(251, 211, 141, 0.16);}@media screen and (min-width: 48em){.css-1xsl8rf{padding-left:var(--chakra-space-8);}}Please enable Javascript to use all features and improve your user experience.

PD Dr. Georg Beyer

Munich / DE

LMU Klinikum

Chair

Fr, 16/02
17:15 – 18:45
Session
Pancreatitis
Plenary

Further involvements

Th, 15/02
16:05 – 16:10 3 Min. 2 Min.
ePoster presentation
P02
Long-term safety and efficacy outcomes of RTX in the different IgG4-RD phenotypes
Acute/chronic pancreatitis
Fr, 16/02
14:15 – 14:20 3 Min. 2 Min.
ePoster presentation
P23
Evaluation of the quality of life in a prospective, longitudinal cohort of patients with pancreatic cancer
Pancreatic cancer
Fr, 16/02
14:35 – 14:40 3 Min. 2 Min.
ePoster presentation
P38
First episode of idiopathic acute pancreatitis does not lead to more severe pancreatitis outcome compared to first time monocausally triggered pancreatitis
Acute/chronic pancreatitis
Fr, 16/02
15:00 – 15:05 3 Min. 2 Min.
ePoster presentation
P32
Severity of gallstone, sludge or microlithiasis induced pancreatitis – all of the same?
Acute/chronic pancreatitis
Fr, 16/02
17:15 – 17:25 8 Min. 2 Min.
Oral presentation
O35
Gut microbiota predicts severity, mortality, length of hospital stay and reveals novel metabolic pathways in severe acute pancreatitis
Acute/chronic pancreatitis
Fr, 16/02
17:25 – 17:35 8 Min. 2 Min.
Oral presentation
O36
Mouse model of biliary pancreatitis: The stepping stone to understand human biliary pancreatitis
Acute/chronic pancreatitis
Fr, 16/02
18:05 – 18:15 8 Min. 2 Min.
Oral presentation
O40
DRACULA – drainage and flushing therapy in necrotizing pancreatitis; a retrospective, multicentric study
Acute/chronic pancreatitis
Sa, 17/02
09:50 – 10:00 8 Min. 2 Min.
Oral presentation
O52
PROTOCOL trial – PROTon pump inhibitors and stent OCclusion rate Of Lumen apposing metal stents
Acute/chronic pancreatitis
Sa, 17/02
10:25 – 10:30 3 Min. 2 Min.
ePoster presentation
P49
Influence of cancer associated fibroblasts (CAFs) heterogeneity on shaping immunosuppressive tumor microenvironment in PDAC
Pancreatic cancer
Sa, 17/02
11:05 – 11:10 3 Min. 2 Min.
ePoster presentation
P77
Depletion of α-SMA+ myofibroblast aggravates pancreatitis in mice
Acute/chronic pancreatitis
Sa, 17/02
13:00 – 13:10 8 Min. 2 Min.
Oral presentation
O56
Irf3 and Irf7 are crucial factors for controlling a tumor-promoting epigenetic program
Pancreatic cancer